US · Healthcare

Xenon Pharmaceuticals Inc (XENE)

Biotechnology

Xenon Pharmaceuticals Inc (XENE) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for XENE

P/E ratio

18.00

Xenon Pharmaceuticals Inc (XENE) — FAQ

What is XENE's P/E ratio?

The price-to-earnings (P/E) ratio for Xenon Pharmaceuticals Inc (XENE) is 18.00 (data as of 2026-03-23).

Does Xenon Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Xenon Pharmaceuticals Inc (XENE). Check the MyAverix Finance app for the latest dividend data.

What sector is Xenon Pharmaceuticals Inc in?

Xenon Pharmaceuticals Inc (XENE) is classified in the Healthcare sector (Biotechnology industry).

What exchange is XENE listed on?

XENE is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)